Spravato offers hope to those with treatment-resistant depression (TRD) who have not found relief from conventional therapies and medications. Typically taken with an oral antidepressant, Spravato can produce long-lasting results in just a few weeks.

Spravato is based on ketamine, an anesthetic that can lead to a diminished or absent sense of pain. It boosts glutamate neurotransmitters to create and strengthen brain pathways to uplift mood and improve overall well-being.